Drug Profile
Oxauracil
Alternative Names: 3-oxauracil; NCI 163038Latest Information Update: 20 Jun 2001
Price :
$50
*
At a glance
- Originator Unknown
- Developer Nonindustrial source
- Class Antineoplastics; Oxazines; Pyridines
- Mechanism of Action RNA synthesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 20 Jun 2001 No-Development-Reported for Cancer in USA (Unknown route)
- 02 Nov 1998 New profile
- 02 Nov 1998 Preclinical development for Cancer in USA (Unknown route)